Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway-Reference-Cited by-全球学者库

Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway

Published:2018-07-03 Issue:13 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:J Am Heart Assoc

Author:

Liu Xiaoxiong¹²³,Yang Qin⁴⁵⁶⁷,Zhu Li‐Hua¹,Liu Jia⁸,Deng Ke‐Qiong¹⁵⁶⁷,Zhu Xue‐Yong¹⁵⁶⁷,Liu Ye⁴⁵⁶⁷,Gong Jun¹⁵⁶⁷,Zhang Peng⁴⁵⁶⁷,Li Shuyan⁸,Xia Hao¹²³,She Zhi‐Gang¹⁵⁶⁷

Affiliation:

1. Department of Cardiology Renmin Hospital of Wuhan University Wuhan China

2. Cardiovascular Research Institute Wuhan University Wuhan China

3. Hubei Key Laboratory of Cardiology Wuhan China

4. Medical Science Research Center Zhongnan Hospital of Wuhan University Wuhan China

5. Institute of Model Animals of Wuhan University Wuhan China

6. Basic Medical School Wuhan University Wuhan China

7. Medical Research Institute School of Medicine Wuhan University Wuhan China

8. Department of Cardiology First Hospital of Jilin University Changchun China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Physiological and pathological cardiac hypertrophy

2. The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

3. Targeting Cardiac Hypertrophy

4. Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy

5. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Sema4D attenuates pressure overload-induced pathological myocardial hypertrophy via the MAPK/NF-κB/NLRP3 pathways;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

2. Simvastatin restores pulmonary endothelial function in the setting of pulmonary over-circulation;Nitric Oxide;2024-01

3. Carboxyl-terminal modulator protein (CTMP) deficiency mitigates denervation-induced skeletal muscle atrophy;Biochemical and Biophysical Research Communications;2023-02

4. Novel Role for Pleckstrin Homology‐Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy;Journal of the American Heart Association;2019-08-20

5. Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway;Journal of Cellular and Molecular Medicine;2019-04-05